Archive for April 30th, 2010

Dendreon Stock/Option Volume Analysis (DNDN)

By now you know the news for Dendreon Corporation (NASDAQ: DNDN).  It turns out that the pre-event snapshot gave a very close and accurate read on what to expect from the volatility trade in options ahead of PROVENGE getting FDA approval. And this morning shares hit yet a new high of $55.00.  At 10:50 AM [...]